Market Tracker

02/19 1:05pm ET

Imprimis Pharmaceuticals Inc (NASDAQ:IMMY)

1.74
Delayed Data
As of Feb 16
 +0.015 / +0.87%
Today’s Change
1.35
Today|||52-Week Range
4.69
+2.06%
Year-to-Date
No recent news for Imprimis Pharmaceuticals Inc.

Today’s Trading

Previous close1.72
Today’s open1.75
Day’s range1.72 - 1.79
Volume152,906
Average volume (3 months)699,481
Market cap$35.6M
Data as of 4:00pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)+9.64%
Earnings growth (this year)+42.67%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+105.25%
P/E ratioNM
Price/Sales1.60
Price/Book5.02

Competitors

 Today’s
change
Today’s
% change
OREXOrexigen Therapeutic...+0.01+1.53%
PRPHProPhase Labs Inc+0.04+1.72%
FCSCFibrocell Science In...+0.00+0.36%
PULMPulmatrix Inc-0.05-3.27%
Data as of 4:00pm ET, 02/16/2018

Financials

Next reporting dateMarch 21, 2018
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$19.9M
Annual profit (last year)-$19.1M
Net profit margin-95.71%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Office &
Director
Mark L. Baum
CFO, Secretary &
Principal Accounting Officer
Andrew R. Boll
Corporate headquarters
San Diego, California

Forecasts